1. Wu JM, Bensen-Kennedy D, Miura Y et al (2005) The effects of interleukin 10 and interferon gamma cytokine gene polymorphisms on survival after autologous bone marrow transplantation for patients with breast cancer. Biol Blood Marrow Transplant 11(6):455–464
2. Stearns ME, Fudge K, Garcia F, Wang M (1997) IL-10 inhibition of human prostate PC-3 ML cell metastases in SCID mice: IL-10 stimulation of TIMP-1 and inhibition of MMP-2/MMP-9 expression. Invasion Metastasis 17(2):62–74
3. Stearns ME, Rhim J, Wang M (1999) Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion. Clin Cancer Res 5(1):189–196
4. Stearns ME, Wang M (1998) Antimestatic and antitumor activities of interleukin 10 in transfected human prostate PC-3 ML clones: orthotopic growth in severe combined immunodeficient mice. Clin Cancer Res 4(9):2257–2263
5. Williams FM, Cherkas LF, Spector TD, MacGregor AJ (2004) A common genetic factor underlies hypertension and other cardiovascular disorders. BMC Cardiovasc Disord 4(1):20